(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.36%) $82.71
(6.71%) $2.05
(0.06%) $2 348.50
(-0.35%) $27.44
(4.07%) $959.60
(-0.20%) $0.933
(-0.33%) $10.99
(-0.54%) $0.796
(1.66%) $93.40
Live Chart Being Loaded With Signals
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular...
Stats | |
---|---|
Dagens volum | 2.06M |
Gjennomsnittsvolum | 191 486 |
Markedsverdi | 175.45B |
EPS | $0.342 ( 2023-09-29 ) |
Last Dividend | $1.375 ( 2023-05-12 ) |
Next Dividend | $0 ( N/A ) |
P/E | 230.53 |
ATR14 | $1.907 (1.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-12 | Fitzgerald Joseph Michael | Sell | 11 660 | Common Stock |
2024-01-09 | Mirviss Jeffrey B. | Buy | 15 172 | Common Stock |
2024-01-09 | Mirviss Jeffrey B. | Sell | 15 172 | Common Stock |
2024-01-09 | Mirviss Jeffrey B. | Sell | 15 172 | Stock Option (Right to Buy) |
2024-01-04 | Mirviss Jeffrey B. | Buy | 15 000 | Common Stock |
INSIDER POWER |
---|
-33.85 |
Last 100 transactions |
Buy: 835 783 | Sell: 1 712 211 |
Volum Korrelasjon
Boston Scientific Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
DTC | 0.915 |
CRD-B | 0.903 |
OR | 0.901 |
CRD-A | 0.895 |
NGG | 0.889 |
IBA | 0.889 |
SQSP | 0.877 |
AGI | 0.876 |
BEST | 0.874 |
USX | 0.873 |
10 Mest negative korrelasjoner | |
---|---|
CBU | -0.894 |
SFUN | -0.888 |
FRC-PI | -0.869 |
GLOP-PC | -0.868 |
FRC-PH | -0.867 |
ASPN | -0.865 |
TDCX | -0.865 |
FRC-PM | -0.864 |
FRC-PN | -0.861 |
FRC-PK | -0.861 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Boston Scientific Korrelasjon - Valuta/Råvare
Boston Scientific Økonomi
Annual | 2023 |
Omsetning: | $14.24B |
Bruttogevinst: | $9.90B (69.49 %) |
EPS: | $1.080 |
FY | 2023 |
Omsetning: | $14.24B |
Bruttogevinst: | $9.90B (69.49 %) |
EPS: | $1.080 |
FY | 2022 |
Omsetning: | $12.68B |
Bruttogevinst: | $8.68B (68.44 %) |
EPS: | $0.450 |
FY | 2021 |
Omsetning: | $11.89B |
Bruttogevinst: | $8.13B (68.37 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Boston Scientific Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$1.375 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $1.436 | 2020-08-13 |
Last Dividend | $1.375 | 2023-05-12 |
Next Dividend | $0 | N/A |
Payout Date | 2023-06-01 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | $8.31 | -- |
Avg. Dividend % Per Year | 1.01% | -- |
Score | 3.22 | -- |
Div. Sustainability Score | 9.85 | |
Div.Growth Potential Score | 5.21 | |
Div. Directional Score | 7.53 | -- |
Year | Amount | Yield |
---|---|---|
2020 | $2.81 | 2.70% |
2021 | $4.13 | 3.80% |
2022 | $0 | 0.00% |
2023 | $1.375 | 1.21% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.121 | 1.500 | 7.59 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0505 | 1.200 | 8.32 | 9.98 | [0 - 0.3] |
returnOnEquityTTM | 0.0955 | 1.500 | -0.0497 | -0.0746 | [0.1 - 1] |
payoutRatioTTM | 0.0158 | -1.000 | 9.84 | -9.84 | [0 - 1] |
currentRatioTTM | 1.320 | 0.800 | 8.40 | 6.72 | [1 - 3] |
quickRatioTTM | 0.627 | 0.800 | -1.018 | -0.814 | [0.8 - 2.5] |
cashRatioTTM | 0.175 | 1.500 | -0.137 | -0.205 | [0.2 - 2] |
debtRatioTTM | 0.270 | -1.500 | 5.50 | -8.25 | [0 - 0.6] |
interestCoverageTTM | 9.20 | 1.000 | 7.70 | 7.70 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.705 | 2.00 | 9.43 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.160 | 2.00 | 9.42 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.492 | -1.500 | 8.03 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.691 | 1.000 | 1.809 | 1.809 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.169 | 1.000 | 8.62 | 8.62 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.264 | 1.000 | 9.65 | 9.65 | [0.2 - 2] |
assetTurnoverTTM | 0.419 | 0.800 | -0.543 | -0.434 | [0.5 - 2] |
Total Score | 9.85 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 60.60 | 1.000 | 3.98 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0955 | 2.50 | -0.0320 | -0.0746 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.160 | 2.00 | 9.61 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.705 | 2.00 | 9.43 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0158 | 1.500 | 9.84 | -9.84 | [0 - 1] |
pegRatioTTM | 0.687 | 1.500 | 8.76 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.170 | 1.000 | 8.25 | 0 | [0.1 - 0.5] |
Total Score | 5.21 |
Boston Scientific
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.